Multiple approved treatments , including copyright and Semaglutide, fall under the incretin mimetic category . Mainly, these therapies help mimicking endogenous hormones that impact blood sugar and https://nicolewqyz173598.arwebo.com/63658520/copyright-and-glp-1-receptor-agonists-getting-to-know-the-treatments